Ono Pharmaceutical
(OTC) OPHLF
Ono Pharmaceutical Financials at a Glance
Market Cap
$6.34B
Revenue (TTM)
¥518.51B
Net Income (TTM)
¥70.20B
EPS (TTM)
$0.99
P/E Ratio
13.59
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Price
$13.50
Volume
32
Open
$13.50
Price
$13.50
Volume
32
Open
$13.50
Previous Close
$13.50
Daily Range
$13.50 - $13.50
52-Week Range
$9.33 - $18.67
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Price
$13.50
Volume
32
Open
$13.50
Previous Close
$13.50
Daily Range
$13.50 - $13.50
52-Week Range
$9.33 - $18.67
Estimated Earnings Date
Aug 3, 2026
OPHLF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ono Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
4,206
CEO
Gyo Sagara
Website
www.ono-pharma.com/jaHeadquarters
Osaka, 541-8564, JP
OPHLF Financials
Key Financial Metrics (TTM)
Gross Margin
72.52%
Operating Margin
20.03%
Net Income Margin
13.53%
Return on Equity
8.54%
Return on Capital
10.63%
Return on Assets
6.31%
Earnings Yield
7.36%
Dividend Yield
3.86%
Payout Ratio
53.80%
Stock Overview
Market Cap
$6.34B
Shares Outstanding
469.91M
Volume
32
Avg. Volume
49.194
Financials (TTM)
Gross Profit
¥376.05B
Operating Income
¥102.68B
EBITDA
¥141.27B
Operating Cash Flow
¥137.90B
Capital Expenditure
-¥6.06B
Free Cash Flow
¥131.84B
Cash & ST Invst.
¥238.60B
Total Debt
¥120.94B
Ono Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
¥119.50B
+6.4%
Gross Profit
¥86.23B
+28.6%
Gross Margin
72.16%
N/A
Market Cap
$6.34B
N/A
Market Cap/Employee
$1.65M
N/A
Employees
3,853
N/A
Net Income
¥823.15M
+112.6%
EBITDA
¥22.16B
+482.8%
Quarterly Fundamentals
Total Cash
¥238.60B
+13.4%
Total Debt
¥120.94B
-17.6%
Accounts Receivable
¥146.85B
+8.8%
Inventory
¥57.81B
-22.8%
Long Term Debt
¥82.99B
-26.9%
Short Term Debt
¥38.47B
+15.9%
Return on Assets
6.31%
N/A
Return on Invested Capital
10.96%
N/A
Free Cash Flow
¥49.42B
+31.5%
Operating Cash Flow
¥50.50B
+29.5%
